The content on this site is intended for healthcare professionals only
The combination of acimtamig and AlloNK therapy demonstrates promising efficacy in R/R cHL
POLA-R-GEMOX regimen is a promising option for relapsed/refractory diffuse large B-cell lymphoma
Ropeginterferon Alfa-2b shows superior efficacy over anagrelide in essential thrombocythaemia
Rusfertide shows promise for polycythemia vera treatment
Understanding AL amyloidosis: Treatment and diagnosis
Bloodstream buzz: Amplifying haematology through social media
Advances in multiple myeloma treatment
Advances in multiple myeloma treatment in the Philippines
Addressing challenges in palliative care
From diagnosis to dignity: Palliative care in multiple myeloma
I can’t wait forever: Treatment of smouldering multiple myeloma (SMM)
Understanding smouldering multiple myeloma: Diagnosis and challenges
